Table 3. Comparison of red cell phospholipid fatty acid composition in healthy subjects and patients with cystic fibrosis (CF).

	Phospholipid fatty acids	Controls	CF patients	p-value
PE	SFA	61,1 (60,6–61,8)	67,8 (52,2–69,0)	0,317
	MUFA	18,6 (18,2–19,8)	27,2 (26,0–33,5)	0,019
	PUFA	19,6 (18,2–20,7)	5,1 (3,4–9,9)	0,002
	UFA	38,9 (38,2–39,4)	33,2 (31,0–47,8)	0,317
	W3	1,1 (1,1–1,4)	0,5 (0,4–0,6)	0,019
	W6	18,2 (17,1–19,3)	4,6 (3,1–8,4)	0,002
PC	SFA	60,7 (58,1–60,8)	74,3 (67,5–78,1)	0,002
	MUFA	24,1 (23,8–24,5)	18,4 (16,6–24,3)	0,125
	PUFA	16,2 (15,3–19,5)	7,6 (4,0–8,3)	0,002
	UFA	39,3 (39,2–41,9)	25,7 (21,9–32,5)	0,002
	W3	<0,01 (<0,01–<0,01)	0,4 (0,3–0,5)	0,002
	W6	16,2 (15,3–19,5)	7,3 (3,5–8,1)	0,002

PE: phosphatidylethanolamine; PC: phosphatidylcholine; SFA: saturated fatty acids, MUFA: monounsaturated fatty acids, PUFA: polyunsaturated fatty acids; UFA: unsaturated fatty acids; W3: n-3 fatty acids; W6: n-6 fatty acids. Data are summarized as medians and interquantile ranges.